Using racial classifications to guide care could result in poorer health outcomes for non-white patients, medical professionals say.
Steps must be taken to prevent bias in sex, gender and race in health data gathered using artificial intelligence, Stanford researchers write.
MicroRNA in the blood holds clues to heart problems in adults born with tetralogy of Fallot, a type of congenital heart disease, Stanford research shows.
As younger adults are being diagnosed with colon cancer, the U.S. Preventive Services Task Force is recommending screening all adults older than 45.
Sampling one's own lower nasal passages for COVID-19 virus is as efficient as swabs that sample deep in the nasal cavity, Stanford study finds.
Stanford researchers are devising new ways to tackle cancer through better, more sophisticated diagnostics and treatments.
PSA testing is an important tool to spot prostate cancer, but it remains a bit confusing. Stanford urologist James Brooks clarifies some misconceptions.
A new cystic fibrosis test could provide a more accurate, and easier, way to test newborns for the hereditary, lung-clogging disease.
Radiologist Ali Tahvildari grapples with how to deliver an uncertain diagnosis. When does causing worry conflict with a doctor's pledge to "do no harm?"
Scientists at Stanford have developed a new PET scan tracer that flags both pancreatic cancer and a lung disease known as idiopathic pulmonary fibrosis.
Researchers at Stanford have created the ultimate consult, pulling from millions of de-identified patient records to better inform the health of others.
Diagnosis of inflammatory bowel disease currently requires an invasive procedure. New research identifies a way to identify the disease using a blood draw.
Inspired by his son's illness, Ron Davis and colleagues have discovered a diagnostic test for chronic fatigue syndrome, a notoriously elusive disease.
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
Study finds that starting colorectal cancer screening at age 45 would avert deaths, but testing more older people would be more beneficial.
A push to personalize medicine can backfire when it comes to screening for colorectal cancer, says a Stanford gastroenterologist.
